Patent · US Active

Multi-functional mucosal vaccine platform

US11185583B2 · kind B2 · utility

0Cited by

2References

2Claims

0Family size

Assignees

Albany Medical College · US
University of Washington through its Center for Commercialization · US

Inventors

Edmund J. Gosselin · North Haverhill, US
Deborah Fuller · Middleton, US

Key dates

Filing date	Feb 11, 2015
Grant date	Nov 30, 2021
Priority date	—
Expiry date	Jun 5, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/40
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An immunogenic fusion protein for use as a mucosal vaccine is provided, which includes: i) one or more FcyR1-binding domains; ii) one or more antigens from one or more infectious disease organisms; and iii) one or more FcRn-binding domains.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.